FromJulie Anne Overton ([email protected])
Subject (106)bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
Preheader (149)͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­
Typography
Arial
Colors
Text Analysis
Body Words3048
Subject Words12
Body Emojis11
Subject Emojis
Media Analysis
Text Links12
Image Links3
Total Links15
Images5
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px2178 px
X-Spam Score0.0
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeEvening

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­ ͏ ‌ ­
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic